CICs are formed by the interaction of antibodies with immunogenic antigens. Immune complexes with only a slight excess of antibody and antigen are soluble and activate complement. CIC formation may be viewed as a host defence mechanism when directed against foreign antigens. Under normal circumstances CICs are cleared by phagocytosis. If CICs escape phagocytotic clearance they may be deposited in endothelial or vascular structures, thus, provoking an inflammatory response leading to tissue damage. CICs have been associated with an increasing variety of diseases, such as autoimmune, rheumatic, infectious, metabolic, renal, hematological and neoplastic diseases. With the CIC ELISA, BÜHLMANN offers clinicians and researchers a tool that provides useful clinical information regarding immunopathology, prognosis, and follow-up of rheumatic and autoimmune disorders.

aProduct Information

CIC
Method	ELISA
Time to results	2 h
Sample Type	20 µl serum or plasma (1:50)
Standard Range	1-50 µg Eq/ml
Sensitivity	< 1 µg Eq/ml
Order Code	EK-CIC 96 wells
	CE

DOWNLOADS
	Instruction for use*	Clinical Information
English	[PDF 0.3MB]	[PDF 0.3MB]

* Multilingual document [EN, DE, FR, IT, ES]